Clinical Trials

Accrual Status
Limit to SWOG Trials

647 Results

View
Status Trial Number Title Activated Closed Accrual Phase Published
Closed S0204 Newly Diagnosed Multiple Myeloma Tandem Transplant 6/15/2002 10/15/2005 100% Published
Closed S0205 PANCREATIC 1/1/2004 4/1/2006 100% Published
Closed S0207 Testicular 4/1/2002 3/1/2005 50% Published
Closed S0211 Ovarian 4/15/2002 1/1/2006 77% Published
Closed S0213 Mantle Cell Lymphoma 10/1/2002 9/1/2006 100% Published
Closed S0215 ADVANCED: Doxetaxel/Vinorelbine/Filgrastim for HER-2 Pos Stage IV Breast Cancer 9/15/2002 1/1/2007 84% Published
Closed S0216 SCCHN 3/1/2003 8/19/2004 100% Published
Closed S0218 Malignant Pleural Mesothelioma 5/1/2002 4/1/2003 100% Published
Closed S0219 Local Bladder 1/1/2003 12/15/2006 81% Published
Closed S0220 Cis/VP-16/RT/Surgery/Doc/Selected IIB, Stage IIIA or IIIB (Pancoast Tumors) 7/1/2003 10/1/2007 92% Published
Closed S0221 ADJUVANT: Continuous Schedule AC + G Vs. Q 2 Week Schedule AC, followed by Paclitaxel 11/1/2003 1/15/2012 100% Published
Closed S0222 TPZ/Cis/VP-16 and RT in Limited SCLC 9/1/2003 7/24/2006 63% Published
Closed S0226 ADVANCED: Anastrozole vs. Anastrozole and Fulvestrant 4/1/2004 7/1/2009 100% Published
Closed S0230 CANCER CONTROL - Prevention of Ovarian Failure Following Chemotherapy in Early Stage Breast Cancer 10/1/2003 56% Published
Closed S0232 Phase III Double-Blinded Placebo Controlled Previously Untreated Multiple Myeloma 11/1/2004 5/11/2007 40% Published
Closed S0301 Phase II Previously Untreated Non-M3 AML in Patients of Age 56 or Older 10/1/2003 12/15/2006 100% Published
Closed S0306 Advanced Bladder 7/15/2003 2/1/2007 100% Published
Closed S0312 Advanced Renal 12/1/2004 8/15/2005 100% Published
Closed S0313 NON-HODGKIN'S: CHOP + IF RT followed by Yttrium-90 Ibritumomab Tiuxetan 2/1/2004 12/15/2008 77% Published
Closed S0316 Barriers to Accrual 8/1/2004 6/15/2008 97% Published
Scroll Table